Stimulan® Rapid Cure 620-020 (UDI 15060155711048)Recalls & reported problems

Summary

The FDA's MAUDE database contains 1 adverse event report that list this exact device (DI 15060155711048), received between Sep 15, 2026 and Sep 15, 2026 — classified as 1 injury.

1 other recall cover devices cleared under the same FDA submission (K141830); they may or may not involve this specific model.

Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 18, 2026.

Most reported problems

Recent adverse event reports

The 1 most recent of 1 reports, in the reporter's own words as published by the FDA.

• InjurySep 15, 2026Adverse Event Without Identified Device or Use Problem

  Patient presented in hospital with high levels of Calcium (20.1 mg/dl) and confusion. During admission. the patient was treated with continuous intravenous fluids, calcitonin 340 units x3 doses, and 1 dose zolendric acid for the treatment of Hypercalcemia.

  Patient problems: Hypercalcemia

  MAUDE report 50777994 ↗

Recalls under the same FDA submission

These recalls involve devices cleared under K141830. One submission often covers many models, so check the product and lot details in each record.

• Z-0638-2021 · Nov 12, 2020 · Terminated
  Stimulan Kit 10cc, Model 600-010 - Product Usage: intended for use as a bone void filler for voids or gaps that are not intrinsic to the stability of the bony structure.